Incremental cost-effectiveness ratios of including pre-adolescent boys in the childhood vaccination program compared to vaccination of pre-adolescent girls only.
Assumes a cost per dose of $75, exclusive of the administration cost (≈$14 per dose).b
Compared to no vaccination.c
Compared to girls-only vaccination.d
Includes female cervical, vulvar, vaginal, anal and oropharyngeal cancers,e
Includes male anal, oropharyngeal and penile cancers,f
Includes cervical, vulvar, vaginal, anal, oropharyngeal and penile cancers related to HPV-16, -18, and genital warts and recurrent respiratory papillomatosis related to HPV-6, -11.